活体人脑AMPA受体的正电子发射断层显像可视化
本研究开发了AMPA受体PET示踪剂[11C]K-2,在健康受试者中证实其脑内可逆性结合,并在颞叶内侧癫痫患者中检出致痫灶摄取增高且与术后AMPA受体蛋白分布相关,提示其可用于神经精神疾病中AMPA受体参与机制的研究。
要点
- [11C]K-2是可特异性结合AMPA受体的PET示踪剂。
- 健康人脑内[11C]K-2结合可逆,符合Logan图形分析。
- 颞叶内侧癫痫致痫灶[11C]K-2摄取增高,与术后AMPA受体蛋白分布相关。
核心结论
- [11C]K-2是有效的AMPA受体PET示踪剂,有望为研究AMPA受体在神经精神疾病中的作用提供工具。
研究设计与样本
- 健康受试者临床试验(UMIN000020975):非随机、单臂;主要结局为[11C]K-2脑内动力学与分布容积,次要结局为给药后4-10天不良事件。
- 癫痫患者探索性临床研究(UMIN000025090):非随机、单臂;主要结局为术前PET[11C]K-2摄取与术后生化检测AMPA受体蛋白密度的相关性,次要结局为PET扫描后7天不良事件。
- 两项试验均达到预设终点。
主要发现
- 健康人脑内[11C]K-2显示可逆性结合,符合Logan图形分析。
- 颞叶内侧癫痫患者致痫灶[11C]K-2摄取增高,且与同个体手术标本局部AMPA受体蛋白分布密切相关。
临床怎么用
- 本研究为探索性阶段,[11C]K-2尚未进入常规临床使用。
- 该示踪剂可为神经精神疾病中AMPA受体参与机制的研究提供活体检测工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although aberrations in the number and function of glutamate AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors are thought to underlie neuropsychiatric disorders, no methods are currently available for visualizing AMPA receptors in the living human brain. Here we developed a positron emission tomography (PET) tracer for AMPA receptors. A derivative of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide radiolabeled with 11C ([11C]K-2) showed specific binding to AMPA receptors. Our clinical trial with healthy human participants confirmed reversible binding of [11C]K-2 in the brain according to Logan graphical analysis (UMIN000020975; study design: non-randomized, single arm; primary outcome: dynamics and distribution volumes of [11C]K-2 in the brain; secondary outcome: adverse events of [11C]K-2 during the 4-10 d following dosing; this trial met prespecified endpoints). In an exploratory clinical study including patients with epilepsy, we detected increased [11C]K-2 uptake in the epileptogenic focus of patients with mesial temporal lobe epilepsy, which was closely correlated with the local AMPA receptor protein distribution in surgical specimens from the same individuals (UMIN000025090; study design: non-randomized, single arm; primary outcome: correlation between [11C]K-2 uptake measured with PET before surgery and AMPA receptor protein density examined by biochemical study after surgery; secondary outcome: adverse events during the 7 d following PET scan; this trial met prespecified endpoints). Thus, [11C]K-2 is a potent PET tracer for AMPA receptors, potentially providing a tool to examine the involvement of AMPA receptors in neuropsychiatric disorders.
引用
- Miyazaki T, Nakajima W, Hatano M, et al. Visualization of AMPA receptors in living human brain with positron emission tomography. Nat Med. 2020. PMID: 31959988. doi:10.1038/s41591-019-0723-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。